Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Lyxor Global Hedge Fund index up 2% in September, 2.8% YTD

Monday, October 18, 2010
Opalesque Industry Update - The Lyxor Global Hedge Fund index, an investable index based on Lyxor’s hedge fund platform which tracks the overall hedge fund universe, was up +2% in September, lifting year to date gains to 2.8%.

Financial markets featured strong trends during the month of September. US equities rallied hard, as did the USD prices of commodities (including precious metals) and foreign currencies such as the euro. Credit market returns were positive but less extreme, with High Yield posting larger gains than Investment Grade. Treasuries were virtually flat on the month.

The Event Driven space provided generally positive returns in September. The Lyxor Special Situations Index gained 4% on the back of equity and credit market gains (with some help from gold); it was the strongest performing Hedge Fund index over the month. Post-reorganization equities, for example, benefited from the positive environment. The Merger Arbitrage Index gained 1.9% as spreads tightened. The Distressed Index was up 0.5%.

The Lyxor L/S Equity Long Bias Index was up 3.9% on the month. Long Bias managers had maintained their exposures during the latter part of the summer and were thus poised to benefit from September’s solid gains in sectors such as basic materials and commodities. The L/S Equity Variable Bias Index was up 1%. Many managers in this space remain defensively positioned despite increasing net exposures over the month of September.

The L/S Equity Market Neutral and Statistical Arbitrage Indexes were both up 0.1%. The Market Neutral Index is the best performing L/S Equity Index year-to-date (+1.6%), reflecting some persistent trends within equities (e.g., Value vs. Growth). Life remains difficult for Statistical Arbitrage managers (the Index is down 2% year-to-date), as correlations among stock returns remain at historically extreme levels and volatility is low.

The Lyxor Long-Term CTA Index continues its run of solid performance, gaining 2.1% (+6.7% on the year). Many of these managers benefited from the persistent equity, commodity, and FX trends. The Short-Term CTA Index was up 0.5%, although the year-to-date performance of 0.4% signals the difficulty some of the managers in this space have experienced. Significant performance dispersion among Short-Term CTAs continues.

The Lyxor Global Macro Index was up 2.5%. Managers with a long commodity bias or short dollar bias readily found traction with these themes.

(press release)

www.lyxorhedgeindices.com


Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und